By Dipo Olowookere Takeda Pharmaceutical Company Limited has disclosed that the global, randomized, Phase 3 ALTA-1L (ALK in Lung Cancer Trial of AP26113 in
By Modupe Gbadeyanka Takeda Pharmaceutical Company Limited today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. for $24.00 per share in cash.
By Dipo Olowookere Takeda Pharmaceutical Company Limited and ARIAD Pharmaceuticals Inc. today announced that they have entered into a definitive agreement under which Takeda
By Modupe Gbadeyanka Japanese firm, Takeda Pharmaceutical Company Limited, has announced that the Biomedical Advanced Research and Development Authority (BARDA) has selected its Vaccine